#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyruvate kinase deficiency anaemia Soft tissue necrosis Retinopathy of prematurity Gastrointestinal stromal tumour Diffuse large B-cell lymphoma Fusarium infection Langerhans' cell histiocytosis Chronic myelomonocytic leukaemia Systemic lupus erythematosus Cerebellar ataxia Thyroid cancer metastatic Kaposi's sarcoma Osteosarcoma recurrent Superficial vein thrombosis Epidermolysis bullosa More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Haemophilia B without inhibitors – Diagnostics Uterine leiomyosarcoma Brain stem glioma – Trials in Disease Angiosarcoma – Diagnostics Factor VIII deficiency – Treatment Activated PI3 kinase delta syndrome – Diagnostics Metachromatic leukodystrophy – Diagnostics IgA nephropathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZAMPILIMAB ALPROSTADIL Sodium Cromoglicate Valproic Acid Cefaclor Litifilimab Cefixime TRIGLYCERIDES MEDIUM CHAIN SIGVOTATUG VEDOTIN Dornase Alfa Interferon Gamma Vorinostat Ads-015 IG-TREGS Emtricitabine Hct116-A Chlorhexidine Dihydrochloride Moxifloxacin Hydrochloride TORASEMIDE NORGESTIMATE More therapies…

    Learn about Your Condition

    Hepatotoxicity Colonoscopy Oropharyngeal cancer Stress cardiomyopathy Lymphatic malformation Immunodeficiency Hyperadrenocorticism Angina pectoris Pyelonephritis Septic shock Dyspnoea Aortic aneurysm Endometrial cancer recurrent Type 1 diabetes mellitus Acute kidney injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effect of Calcium Folinate, Gemcitabine, and Fluorouracil in Patients with Advanced Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Calcium Folinate
    • Fluorouracil
    Germany Sweden

  • Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin Hydrochloride Monohydrate
    • Clindamycin
    • Minocycline
    Belgium The Netherlands

  • Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated Drugs:
    • Vinblastine Sulfate
    Austria Belgium Denmark Finland France Germany +2

  • Study on Lansoprazole for Preventing Acid Reflux in Patients with Esophageal Achalasia After Endoscopic Myotomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal achalasia
    Investigated Drugs:
    • Lansoprazole
    France

  • Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction

    Recruiting

    4 1
    Investigated Drugs:
    • Vericiguat
    Belgium Croatia Denmark Finland France Germany +8

  • Study on the Effectiveness of Reconsolidation Therapy with Propranolol for Patients with Severe Post-Traumatic Stress Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    Belgium
Previous Page
1 … 578 579 580 581 582 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!